Red Flags Detected
- Delisting (new) — Company received formal Nasdaq notice for failing minimum stockholders' equity requirement and faces potential delisting if unable to regain compliance.
Vivos Therapeutics receives Nasdaq delisting notice over negative stockholders' equity
Filed April 22, 2026 · Period ending April 22, 2026 · ~1 min read
4 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade VVOS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 3, 2026 12:54 AM